Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Ophthalmology Surgical Services Market: By Product, By End-Users and Region 2020-2031
Ophthalmology Surgical Services Market size was valued at US$ 8,952.1 million in 2024 and is projected to reach US$ 12,596.5 million by 2031 at a CAGR of 5.1% from 2025-2031. Moreover, the U.S. market is projected to grow at 4.8% CAGR over the forecast period. The market encompasses the segment of healthcare focused on the diagnosis, surgical treatment, and management of eye-related conditions, including cataracts, glaucoma, retinal disorders, refractive errors, and corneal diseases. This market integrates a wide range of procedures such as laser-assisted surgeries, minimally invasive techniques, and complex microsurgeries.
It includes services offered in hospitals, ambulatory surgical centers, and specialty eye clinics, often supported by technologically advanced tools such as phacoemulsification systems, femtosecond lasers, and intraocular lenses (IOLs). The sector is driven by the demand for vision correction and preventive care among aging populations and individuals with chronic diseases such as diabetes. The global market has witnessed significant growth due to rising incidences of age-related macular degeneration, cataracts, and diabetic retinopathy.
Moreover, the increased availability of outpatient surgical care, the expansion of vision care infrastructure in emerging economies, and the integration of AI and image-guided systems are enhancing patient outcomes and boosting procedural efficiency. The market also benefits from growing public and private investments in ophthalmic care and a surge in medical tourism for cost-effective eye surgeries, particularly in countries across Asia-Pacific and Latin America.
Based on the product, the market is segmented into the following
Among the various product segments in the ophthalmology surgical services market, cataract surgery devices are anticipated to lead the market growth, driven by the global burden of cataracts and increasing demand for advanced surgical solutions. Cataract remains the leading cause of blindness worldwide, affecting more than 94 million people, according to the World Health Organization. As populations age particularly in regions like Asia-Pacific and Europe—the need for cataract correction is accelerating rapidly. Intraocular lenses (IOLs), a subsegment within cataract surgery devices, are witnessing growing demand due to innovations such as multifocal and toric lenses that offer improved postoperative vision and reduce dependence on glasses.
Moreover, the adoption of phacoemulsification systems and femtosecond laser-assisted cataract surgery (FLACS) has significantly enhanced surgical precision and patient outcomes. The rise in outpatient cataract procedures, supported by government-funded programs in emerging markets, further fuels this segment’s dominance. As a result, cataract surgery devices remain the most influential product category in driving overall market expansion.
Based on the end-user
The Hospitals are anticipated to lead the ophthalmology surgical services market, primarily driven by their comprehensive infrastructure, access to advanced technologies, and ability to handle complex surgical cases. Hospitals often serve as referral centers for high-risk or multi-disciplinary ophthalmic procedures, particularly in cases involving comorbid conditions like diabetes or glaucoma. They are better equipped with high-end surgical platforms, including femtosecond lasers, phacoemulsification units, and intraoperative imaging systems, which contribute to improved surgical outcomes.
Additionally, hospitals are more likely to be integrated into national healthcare programs and insurance networks, which enhances patient affordability and access. The growing prevalence of age-related ocular disorders, coupled with rising surgical volumes in urban hospitals, further cements their dominant role in the market. Teaching hospitals and tertiary care centers also contribute significantly by advancing ophthalmic research and clinical innovation. As a result, hospitals remain the primary setting for high-quality, large-scale ophthalmic surgical services globally.
Study Period
2025-2031Base Year
2024CAGR
5.1%Largest Market
Asia-PacificFastest Growing Market
Latin America
One of the key factors boosting the ophthalmology surgical services market is the rising number of cataracts and other age-related eye issues, like macular degeneration and glaucoma. As populations around the world age especially in countries such as Japan, Germany, and the United States the need for surgeries that restore vision is on the upswing. Cataracts are still the leading cause of blindness globally, and surgical treatment for them is among the most frequently performed medical procedures in history.
The World Health Organization (WHO) estimates that over 94 million people worldwide are affected by cataracts, many of whom will need surgery. This demographic change, along with a growing awareness of the importance of eye care, is driving the growth of both public and private surgical centers that are equipped with cutting-edge ophthalmic technology. Moreover, government-supported eye care initiatives in developing countries are improving access to affordable surgeries, making cataract removal more common and significantly propelling the overall market forward.
Even with all the progress we've made in eye surgery techniques, the hefty price tag that comes with advanced surgical tools and high-end intraocular lenses (IOLs) is a significant hurdle for the market. Innovations like femtosecond lasers, robotic-assisted systems, and premium toric/multifocal IOLs deliver impressive results, but they also bring along much higher operational and maintenance costs. Unfortunately, these expenses often get passed down to patients, particularly in areas where insurance or public health coverage isn't robust, making it tough for many to afford the care they need.
In low- and middle-income countries, the uptake of these advanced technologies is even more limited due to budget constraints, a shortage of trained professionals, and inadequate healthcare infrastructure. Even in wealthier nations, reimbursement challenges can hold back ophthalmic centers from upgrading to the latest systems, especially when insurers focus more on cost savings than on fostering innovation. Consequently, while the demand for these services keeps rising, the availability of cutting-edge surgical options is still quite uneven around the world, leading to a situation where advanced care is mostly accessible to those who can afford it.
The swift rise of ambulatory surgical centers (ASCs) and eye hospitals in developing countries is creating a fantastic opportunity for growth in the ophthalmology surgical services market. Nations like India, China, Brazil, and Indonesia are seeing a surge in public-private partnerships that aim to enhance eye care infrastructure. These outpatient facilities, which focus on high-volume, low-cost cataract and refractive surgeries, play a crucial role in alleviating surgical backlogs and boosting patient outcomes.
For instance, Aravind Eye Care in India has showcased effective models for providing affordable eye surgeries, performing millions of procedures each year while ensuring quality and cost-efficiency. Additionally, increased investments in healthcare digitization, tele-ophthalmology, and mobile eye units are paving the way for earlier diagnoses and higher surgical conversion rates in underserved regions. With a growing number of trained ophthalmic professionals, supportive government policies, and rising disposable incomes, these emerging areas are evolving into centers of surgical innovation and accessibility unlocking a wealth of potential for market growth.
A significant trend that's shaking up the world of ophthalmology surgical services is the incorporation of artificial intelligence (AI), machine learning, and image-guided technologies into everyday clinical practices. These cutting-edge innovations are not just improving surgical planning and precision; they're also boosting patient outcomes across a range of ophthalmic procedures. With AI-driven diagnostic tools, we can now detect cataracts, glaucoma, and retinal diseases with almost human-like accuracy, paving the way for earlier interventions and better surgical preparedness. Intraoperative guidance systems, like real-time optical coherence tomography (OCT) and digital marking tools, are enhancing the precision of incisions and intraocular lens (IOL) placements, which helps to minimize postoperative complications and supports quicker visual recovery.
Companies such as Alcon, Carl Zeiss Meditec, and Johnson & Johnson Vision are pouring resources into smart surgical ecosystems that blend advanced imaging, robotics, and cloud-based data analytics. These technologies are also making their way into outpatient settings, signaling a move towards more personalized and precision-focused surgery. As we embrace digitalization, the use of AI and image guidance is poised to transform the standards of care in ophthalmic surgery around the world.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2024 |
US$ 8,952.1 million |
Market Size in 2031 |
US$ 12,596.5 million |
Market CAGR |
5.1% |
By Product Type |
|
By End User |
|
By Region |
|
PBI Analysts view the global the surgical services market in ophthalmology is witnessing robust growth, driven by rising global demand for vision restoration and technological advancements in eye surgery. Analysts observe that the market is primarily fueled by the increasing prevalence of cataracts, glaucoma, and age-related macular degeneration, particularly among aging populations in both developed and emerging economies. Cataract surgery continues to dominate, with innovations in intraocular lenses (IOLs) and femtosecond laser systems significantly improving patient outcomes.
Furthermore, the shift toward outpatient procedures in ambulatory surgical centers and ophthalmic clinics is enhancing efficiency and reducing surgical costs. Analysts also highlight the role of digital integration, such as AI-guided diagnostics and real-time imaging, in boosting precision and surgical success rates. Emerging markets in Asia-Pacific and Latin America are showing accelerated growth due to expanding healthcare infrastructure and public health initiatives. Overall, the ophthalmic surgical services market is evolving rapidly, combining clinical innovation with broader access to improve global eye health outcomes.
Download Free Sample Report
Ophthalmology Surgical Services Market size was valued at US$ 8,952.1 million in 2024 and is projected to reach US$ 12,596.5 million by 2031 at a CAGR of 5.1% from 2025-2031.
The surgical services market in ophthalmology is driven by the increasing prevalence of cataracts and age-related eye disorders worldwide.
Integration of AI and image-guided technologies is transforming surgical precision and patient outcomes in ophthalmic procedures.
Rapid expansion of affordable outpatient surgical centers in Latin America is fueling market growth in emerging regions.
1.Executive Summary |
2.Global Ophthalmology Surgical Services Market Introduction |
2.1.Global Ophthalmology Surgical Services Market - Taxonomy |
2.2.Global Ophthalmology Surgical Services Market - Definitions |
2.2.1.Product |
2.2.2.End-user |
2.2.3.Region |
3.Global Ophthalmology Surgical Services Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Ophthalmology Surgical Services Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Ophthalmology Surgical Services Market By Product, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
5.1. Cataract Surgery Devices (Intraocular Lenses (IOLs), Ophthalmic Viscoelastic Devices, Others) |
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Glaucoma Surgery Devices |
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Vitreoretinal Surgery Devices |
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Refractive Surgery Devices |
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Ophthalmology Surgical Services Market By End-user, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Ambulatory Surgical Centers |
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Ophthalmic Clinics |
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Ophthalmology Surgical Services Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Ophthalmology Surgical Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
8.1. Product Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Cataract Surgery Devices (Intraocular Lenses (IOLs), Ophthalmic Viscoelastic Devices, Others) |
8.1.2.Glaucoma Surgery Devices |
8.1.3.Vitreoretinal Surgery Devices |
8.1.4.Refractive Surgery Devices |
8.2. End-user Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Hospitals |
8.2.2.Ambulatory Surgical Centers |
8.2.3.Ophthalmic Clinics |
8.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Ophthalmology Surgical Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
9.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Cataract Surgery Devices (Intraocular Lenses (IOLs), Ophthalmic Viscoelastic Devices, Others) |
9.1.2.Glaucoma Surgery Devices |
9.1.3.Vitreoretinal Surgery Devices |
9.1.4.Refractive Surgery Devices |
9.2. End-user Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospitals |
9.2.2.Ambulatory Surgical Centers |
9.2.3.Ophthalmic Clinics |
9.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Ophthalmology Surgical Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Cataract Surgery Devices (Intraocular Lenses (IOLs), Ophthalmic Viscoelastic Devices, Others) |
10.1.2.Glaucoma Surgery Devices |
10.1.3.Vitreoretinal Surgery Devices |
10.1.4.Refractive Surgery Devices |
10.2. End-user Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospitals |
10.2.2.Ambulatory Surgical Centers |
10.2.3.Ophthalmic Clinics |
10.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Ophthalmology Surgical Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Cataract Surgery Devices (Intraocular Lenses (IOLs), Ophthalmic Viscoelastic Devices, Others) |
11.1.2.Glaucoma Surgery Devices |
11.1.3.Vitreoretinal Surgery Devices |
11.1.4.Refractive Surgery Devices |
11.2. End-user Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospitals |
11.2.2.Ambulatory Surgical Centers |
11.2.3.Ophthalmic Clinics |
11.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Ophthalmology Surgical Services Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Cataract Surgery Devices (Intraocular Lenses (IOLs), Ophthalmic Viscoelastic Devices, Others) |
12.1.2.Glaucoma Surgery Devices |
12.1.3.Vitreoretinal Surgery Devices |
12.1.4.Refractive Surgery Devices |
12.2. End-user Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospitals |
12.2.2.Ambulatory Surgical Centers |
12.2.3.Ophthalmic Clinics |
12.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Alcon Inc., |
13.2.2.Johnson & Johnson Vision, |
13.2.3.Bausch + Lomb, |
13.2.4.Carl Zeiss |
13.2.5.Meditec AG, |
13.2.6.HOYA Corporation, |
13.2.7.NIDEK Co., Ltd., |
13.2.8.STAAR Surgical Company, |
13.2.9.Glaukos Corporation, |
13.2.10.Topcon Corporation, |
13.2.11.Lumenis Ltd. |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players